Heartburn Meds Could Up Risk Of Fractures: FDA

Law360, New York (May 26, 2010, 6:14 PM EDT) -- The U.S. Food and Drug Administration is requiring new warnings on AstraZeneca's Prilosec, Pfizer Inc.'s Protonix, Takeda Pharmaceutical Co. Ltd.'s Prevacid and other acid reflux and ulcer drugs to reflect a possible increased risk of hip, wrist and spine fractures.

Data cited by the FDA revealed that individuals who took the drugs, especially in high doses or for a period of one year or more, were at an increased risk of the bone fractures, the agency said Monday.

Most of the studies tracked people over 50,...
To view the full article, register now.